Cancer anorexia-cachexia syndrome

Cytokines and neuropeptides

Eduardo J B Ramos, Susumu Suzuki, Daniel Marks, Akio Inui, Akihiro Asakawa, Michael M. Meguid

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Purpose of review: Cancer anorexia-cachexia syndrome is observed in 80% of patients in the advanced stages of cancer and is a strong independent risk factor for mortality. Numerous cytokines produced by tumor and immune cells, interacting with the neuropeptidergic system, mediate the cachectic effect of cancer. Since there is currently no effective pharmacological treatment and the anorexia-cachexia syndrome continues to be defined biochemically, we review the role of cytokines and neuropeptides in this process. Recent findings: Currently data suggest that cancer anorexia-cachexia syndrome results from a multifactorial process involving many mediators, including hormones (e.g. leptin), neuropeptides (e.g. neuropeptide Y, melanocortin, melanin-concentrating hormone and orexin) and cytokines (e.g. interleukin 1, interleukin 6, tumor necrosis factor α; and Interferon γ). It is likely that close interrelation among these mediators exists in the hypothalamus, decreasing food intake and leading to cachexia. Summary: In the pathogenesis of cancer anorexia, cytokines play a pivotal role influencing the imbalance of orexigenic and anorexigenic circuits that regulate the homeostatic loop of body-weight regulation, leading to cachexia. Interfering pharmacologically with cytokine expression or neural transduction of cytokine signals can be an effective therapeutic strategy in anorectic patients before they develop cancer anorexia-cachexia syndrome.

Original languageEnglish (US)
Pages (from-to)427-434
Number of pages8
JournalCurrent Opinion in Clinical Nutrition and Metabolic Care
Volume7
Issue number4
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

cachexia
Cachexia
neuropeptides
Anorexia
Neuropeptides
anorexia
cytokines
Cytokines
neoplasms
Neoplasms
hormones
Melanocortins
Appetite Depressants
neuropeptide Y
tumor necrosis factors
Neuropeptide Y
interleukin-1
melanin
interferons
concentrating

Keywords

  • Anorexia
  • Cachexia
  • Cytokine
  • Neuropeptide

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Endocrinology
  • Food Science
  • Endocrinology, Diabetes and Metabolism

Cite this

Cancer anorexia-cachexia syndrome : Cytokines and neuropeptides. / Ramos, Eduardo J B; Suzuki, Susumu; Marks, Daniel; Inui, Akio; Asakawa, Akihiro; Meguid, Michael M.

In: Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 7, No. 4, 07.2004, p. 427-434.

Research output: Contribution to journalArticle

Ramos, Eduardo J B ; Suzuki, Susumu ; Marks, Daniel ; Inui, Akio ; Asakawa, Akihiro ; Meguid, Michael M. / Cancer anorexia-cachexia syndrome : Cytokines and neuropeptides. In: Current Opinion in Clinical Nutrition and Metabolic Care. 2004 ; Vol. 7, No. 4. pp. 427-434.
@article{13672c767d93403cad69fa006965963e,
title = "Cancer anorexia-cachexia syndrome: Cytokines and neuropeptides",
abstract = "Purpose of review: Cancer anorexia-cachexia syndrome is observed in 80{\%} of patients in the advanced stages of cancer and is a strong independent risk factor for mortality. Numerous cytokines produced by tumor and immune cells, interacting with the neuropeptidergic system, mediate the cachectic effect of cancer. Since there is currently no effective pharmacological treatment and the anorexia-cachexia syndrome continues to be defined biochemically, we review the role of cytokines and neuropeptides in this process. Recent findings: Currently data suggest that cancer anorexia-cachexia syndrome results from a multifactorial process involving many mediators, including hormones (e.g. leptin), neuropeptides (e.g. neuropeptide Y, melanocortin, melanin-concentrating hormone and orexin) and cytokines (e.g. interleukin 1, interleukin 6, tumor necrosis factor α; and Interferon γ). It is likely that close interrelation among these mediators exists in the hypothalamus, decreasing food intake and leading to cachexia. Summary: In the pathogenesis of cancer anorexia, cytokines play a pivotal role influencing the imbalance of orexigenic and anorexigenic circuits that regulate the homeostatic loop of body-weight regulation, leading to cachexia. Interfering pharmacologically with cytokine expression or neural transduction of cytokine signals can be an effective therapeutic strategy in anorectic patients before they develop cancer anorexia-cachexia syndrome.",
keywords = "Anorexia, Cachexia, Cytokine, Neuropeptide",
author = "Ramos, {Eduardo J B} and Susumu Suzuki and Daniel Marks and Akio Inui and Akihiro Asakawa and Meguid, {Michael M.}",
year = "2004",
month = "7",
doi = "10.1097/01.mco.0000134363.53782.cb",
language = "English (US)",
volume = "7",
pages = "427--434",
journal = "Current Opinion in Clinical Nutrition and Metabolic Care",
issn = "1363-1950",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cancer anorexia-cachexia syndrome

T2 - Cytokines and neuropeptides

AU - Ramos, Eduardo J B

AU - Suzuki, Susumu

AU - Marks, Daniel

AU - Inui, Akio

AU - Asakawa, Akihiro

AU - Meguid, Michael M.

PY - 2004/7

Y1 - 2004/7

N2 - Purpose of review: Cancer anorexia-cachexia syndrome is observed in 80% of patients in the advanced stages of cancer and is a strong independent risk factor for mortality. Numerous cytokines produced by tumor and immune cells, interacting with the neuropeptidergic system, mediate the cachectic effect of cancer. Since there is currently no effective pharmacological treatment and the anorexia-cachexia syndrome continues to be defined biochemically, we review the role of cytokines and neuropeptides in this process. Recent findings: Currently data suggest that cancer anorexia-cachexia syndrome results from a multifactorial process involving many mediators, including hormones (e.g. leptin), neuropeptides (e.g. neuropeptide Y, melanocortin, melanin-concentrating hormone and orexin) and cytokines (e.g. interleukin 1, interleukin 6, tumor necrosis factor α; and Interferon γ). It is likely that close interrelation among these mediators exists in the hypothalamus, decreasing food intake and leading to cachexia. Summary: In the pathogenesis of cancer anorexia, cytokines play a pivotal role influencing the imbalance of orexigenic and anorexigenic circuits that regulate the homeostatic loop of body-weight regulation, leading to cachexia. Interfering pharmacologically with cytokine expression or neural transduction of cytokine signals can be an effective therapeutic strategy in anorectic patients before they develop cancer anorexia-cachexia syndrome.

AB - Purpose of review: Cancer anorexia-cachexia syndrome is observed in 80% of patients in the advanced stages of cancer and is a strong independent risk factor for mortality. Numerous cytokines produced by tumor and immune cells, interacting with the neuropeptidergic system, mediate the cachectic effect of cancer. Since there is currently no effective pharmacological treatment and the anorexia-cachexia syndrome continues to be defined biochemically, we review the role of cytokines and neuropeptides in this process. Recent findings: Currently data suggest that cancer anorexia-cachexia syndrome results from a multifactorial process involving many mediators, including hormones (e.g. leptin), neuropeptides (e.g. neuropeptide Y, melanocortin, melanin-concentrating hormone and orexin) and cytokines (e.g. interleukin 1, interleukin 6, tumor necrosis factor α; and Interferon γ). It is likely that close interrelation among these mediators exists in the hypothalamus, decreasing food intake and leading to cachexia. Summary: In the pathogenesis of cancer anorexia, cytokines play a pivotal role influencing the imbalance of orexigenic and anorexigenic circuits that regulate the homeostatic loop of body-weight regulation, leading to cachexia. Interfering pharmacologically with cytokine expression or neural transduction of cytokine signals can be an effective therapeutic strategy in anorectic patients before they develop cancer anorexia-cachexia syndrome.

KW - Anorexia

KW - Cachexia

KW - Cytokine

KW - Neuropeptide

UR - http://www.scopus.com/inward/record.url?scp=14844320127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844320127&partnerID=8YFLogxK

U2 - 10.1097/01.mco.0000134363.53782.cb

DO - 10.1097/01.mco.0000134363.53782.cb

M3 - Article

VL - 7

SP - 427

EP - 434

JO - Current Opinion in Clinical Nutrition and Metabolic Care

JF - Current Opinion in Clinical Nutrition and Metabolic Care

SN - 1363-1950

IS - 4

ER -